An estimated 145,000 men and women will be diagnosed with colorectal cancer in 2019 and 51,000 individuals are estimated to die from the disease. Without a continued, dedicated federal investment in colorectal cancer prevention and early detection, the U.S. could experience a reduction in screening leading to increases in completely preventable colorectal cancer cases and deaths. This factsheet discusses the importance of continued funding for the Colorectal Cancer Control Program (CRCCP).
NBCCEDP – a Centers for Disease Control and Prevention (CDC) program – provides low-income, uninsured, and underinsured women access to breast and cervical cancer screenings and diagnostic services. Ensuring adequate funding for the NBCCEDP will preserve a critical safety net for American women who continue to lack access to lifesaving screening, diagnostic, and treatment services for breast and cervical cancers.
Colorectal cancer is the third most common cancer in men and women and the second leading cause of cancer death in men and women combined in the United States. Yet, more than 1 in 3 adults age 50 and older are not getting tested as recommended. This factsheet discusses the importance of screening for colorectal cancer and what can be done to improve screening in the U.S.
If detected early, cervical cancer is one of the most successfully treatable cancers. Incidence and mortality rates of cervical cancer have declined by over 50 percent in the past 50 years, largely due to improved screening and early detection. However, the rate of decline has slowed in recent years. Efforts to reduce barriers to screening could greatly improve cervical cancer screening rates, particularly for disparate populations.
Colorectal cancer is unique in that a person can be spared a cancer diagnosis if a polyp is found early and removed during the screening process. Right now, Medicare beneficiaries face a surprise bill when they wake up from a cancer screening that could save their life, thinking it was free. That's why it's so important to remove barriers to screening to ensure that all Americans have access.
Testimony Submitted to the Senate Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs, for Fiscal Year 2018 in support of a proposed statutory proviso that would encourage the Department of State and the U.S. Agency for International Development (USAID) to take steps toward eliminating cervical cancer deaths worldwide.
Testimony Submitted to the House Committee on Appropriations, Subcommittee on State, Foreign Operations, and Related Programs, For Fiscal Year 2018 in support of a proposed statutory proviso that would encourage the Department of State and the U.S. Agency for International Development (USAID) to take steps toward eliminating cervical cancer deaths worldwide.